$ENDV Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ENDONOVO THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ENDONOVO THERAPEUTICS, INC.. Get notifications about new insider transactions in ENDONOVO THERAPEUTICS, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 07 2020 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.10 | 100 | 10 | 26,219 | 26.1 K to 26.2 K (+0.38 %) |
Jul 07 2020 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.10 | 100 | 10 | 26,119 | 26 K to 26.1 K (+0.38 %) |
Jul 07 2020 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.10 | 200 | 21 | 26,019 | 25.8 K to 26 K (+0.77 %) |
Feb 26 2020 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Director | Buy | P | 0.96 | 100 | 96 | 25,819 | 25.7 K to 25.8 K (+0.39 %) |
Jan 23 2020 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 1.75 | 100 | 175 | 25,418,897 | 25.4 M to 25.4 M (0.00 %) |
Jan 23 2020 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 2.25 | 100 | 225 | 25,418,797 | 25.4 M to 25.4 M (0.00 %) |
Dec 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 100 | 0 | 25,418,697 | 25.4 M to 25.4 M (0.00 %) |
Dec 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 500 | 1 | 25,418,597 | 25.4 M to 25.4 M (0.00 %) |
Dec 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 1,000 | 2 | 25,418,097 | 25.4 M to 25.4 M (0.00 %) |
Dec 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 100 | 0 | 25,417,097 | 25.4 M to 25.4 M (0.00 %) |
Dec 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 1,000 | 2 | 25,416,997 | 25.4 M to 25.4 M (0.00 %) |
Dec 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 1,000 | 3 | 25,415,997 | 25.4 M to 25.4 M (0.00 %) |
Dec 31 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 2,000 | 6 | 25,414,997 | 25.4 M to 25.4 M (+0.01 %) |
Dec 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 2,000 | 6 | 25,412,997 | 25.4 M to 25.4 M (+0.01 %) |
Dec 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 2,000 | 6 | 25,410,997 | 25.4 M to 25.4 M (+0.01 %) |
Dec 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 2,000 | 6 | 25,408,997 | 25.4 M to 25.4 M (+0.01 %) |
Dec 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 2,000 | 6 | 25,406,997 | 25.4 M to 25.4 M (+0.01 %) |
Dec 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 2,000 | 6 | 25,404,997 | 25.4 M to 25.4 M (+0.01 %) |
Dec 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 2,000 | 7 | 25,402,997 | 25.4 M to 25.4 M (+0.01 %) |
Dec 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 1,000 | 4 | 25,400,997 | 25.4 M to 25.4 M (0.00 %) |
Dec 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 2,000 | 7 | 25,399,997 | 25.4 M to 25.4 M (+0.01 %) |
Nov 26 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 1,000 | 4 | 25,397,997 | 25.4 M to 25.4 M (0.00 %) |
Nov 26 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 1,000 | 4 | 25,396,997 | 25.4 M to 25.4 M (0.00 %) |
Nov 26 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.00 | 1,000 | 4 | 25,395,997 | 25.4 M to 25.4 M (0.00 %) |
Nov 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | Ceo | Buy | P | 0.01 | 2,000 | 14 | 25,394,997 | 25.4 M to 25.4 M (+0.01 %) |
Nov 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 58 | 25,392,997 | 25.4 M to 25.4 M (+0.04 %) |
Nov 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 30 | 25,382,997 | 25.4 M to 25.4 M (+0.02 %) |
Nov 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 30 | 25,377,997 | 25.4 M to 25.4 M (+0.02 %) |
Nov 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.00 | 5,000 | 25 | 25,372,997 | 25.4 M to 25.4 M (+0.02 %) |
Nov 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.00 | 5,000 | 25 | 25,367,997 | 25.4 M to 25.4 M (+0.02 %) |
Nov 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.00 | 5,000 | 22 | 25,362,997 | 25.4 M to 25.4 M (+0.02 %) |
Nov 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.00 | 5,000 | 24 | 25,357,997 | 25.4 M to 25.4 M (+0.02 %) |
Nov 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.00 | 5,000 | 23 | 25,352,997 | 25.3 M to 25.4 M (+0.02 %) |
Nov 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.00 | 5,000 | 24 | 25,347,997 | 25.3 M to 25.3 M (+0.02 %) |
Nov 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 500 | 5 | 25,342,997 | 25.3 M to 25.3 M (0.00 %) |
Nov 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 500 | 4 | 25,342,497 | 25.3 M to 25.3 M (0.00 %) |
Nov 04 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 200 | 2 | 25,341,997 | 25.3 M to 25.3 M (0.00 %) |
Oct 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 200 | 2 | 25,341,797 | 25.3 M to 25.3 M (0.00 %) |
Oct 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 25,341,597 | 25.3 M to 25.3 M (+0.01 %) |
Oct 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 200 | 2 | 25,339,797 | 25.3 M to 25.3 M (0.00 %) |
Oct 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 25,339,597 | 25.3 M to 25.3 M (+0.01 %) |
Oct 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 1,000 | 10 | 25,337,597 | 25.3 M to 25.3 M (0.00 %) |
Oct 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 25,336,597 | 25.3 M to 25.3 M (+0.01 %) |
Oct 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 25,334,597 | 25.3 M to 25.3 M (+0.01 %) |
Oct 15 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 1,000 | 10 | 25,332,597 | 25.3 M to 25.3 M (0.00 %) |
Oct 03 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 100 | 1 | 25,331,597 | 25.3 M to 25.3 M (0.00 %) |
Oct 03 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 100 | 1 | 25,331,497 | 25.3 M to 25.3 M (0.00 %) |
Oct 03 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 100 | 1 | 25,331,397 | 25.3 M to 25.3 M (0.00 %) |
Oct 03 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 100 | 1 | 25,331,297 | 25.3 M to 25.3 M (0.00 %) |
Oct 03 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 100 | 1 | 25,331,197 | 25.3 M to 25.3 M (0.00 %) |
Oct 03 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 100 | 1 | 25,331,097 | 25.3 M to 25.3 M (0.00 %) |
Sep 27 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 200 | 1 | 25,330,997 | 25.3 M to 25.3 M (0.00 %) |
Sep 27 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 200 | 1 | 25,330,797 | 25.3 M to 25.3 M (0.00 %) |
Sep 27 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 100 | 1 | 25,330,597 | 25.3 M to 25.3 M (0.00 %) |
Sep 27 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 100 | 1 | 25,330,497 | 25.3 M to 25.3 M (0.00 %) |
Sep 27 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 100 | 1 | 25,330,397 | 25.3 M to 25.3 M (0.00 %) |
Sep 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 18 | 25,330,297 | 25.3 M to 25.3 M (+0.01 %) |
Sep 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 17 | 25,328,297 | 25.3 M to 25.3 M (+0.01 %) |
Sep 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 19 | 25,326,297 | 25.3 M to 25.3 M (+0.01 %) |
Sep 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 19 | 25,324,297 | 25.3 M to 25.3 M (+0.01 %) |
Sep 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 17 | 25,322,297 | 25.3 M to 25.3 M (+0.01 %) |
Sep 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 41 | 25,320,297 | 25.3 M to 25.3 M (+0.02 %) |
Sep 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 25,315,297 | 25.3 M to 25.3 M (+0.01 %) |
Sep 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 46 | 25,313,297 | 25.3 M to 25.3 M (+0.02 %) |
Sep 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 46 | 25,308,297 | 25.3 M to 25.3 M (+0.02 %) |
Sep 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 46 | 25,303,297 | 25.3 M to 25.3 M (+0.02 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 49 | 25,298,297 | 25.3 M to 25.3 M (+0.02 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 49 | 25,293,297 | 25.3 M to 25.3 M (+0.02 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 47 | 25,288,297 | 25.3 M to 25.3 M (+0.02 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 46 | 25,283,297 | 25.3 M to 25.3 M (+0.02 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 47 | 25,278,297 | 25.3 M to 25.3 M (+0.02 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 98 | 25,273,297 | 25.3 M to 25.3 M (+0.04 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 15,000 | 140 | 25,263,297 | 25.2 M to 25.3 M (+0.06 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 93 | 25,248,297 | 25.2 M to 25.2 M (+0.04 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 99 | 25,238,297 | 25.2 M to 25.2 M (+0.04 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 50 | 25,228,297 | 25.2 M to 25.2 M (+0.02 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 15,000 | 150 | 25,223,297 | 25.2 M to 25.2 M (+0.06 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 50 | 25,208,297 | 25.2 M to 25.2 M (+0.02 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 25,203,297 | 25.2 M to 25.2 M (+0.02 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 51 | 25,198,297 | 25.2 M to 25.2 M (+0.02 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 52 | 25,193,297 | 25.2 M to 25.2 M (+0.02 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 25,188,297 | 25.2 M to 25.2 M (+0.01 %) |
Sep 06 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 25,186,297 | 25.2 M to 25.2 M (+0.01 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 25,184,297 | 25.2 M to 25.2 M (+0.01 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 25,182,297 | 25.2 M to 25.2 M (+0.01 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 25,180,297 | 25.2 M to 25.2 M (+0.01 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 15,000 | 152 | 25,178,297 | 25.2 M to 25.2 M (+0.06 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 25,163,297 | 25.2 M to 25.2 M (+0.01 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 25,161,297 | 25.2 M to 25.2 M (+0.01 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 210 | 25,159,297 | 25.1 M to 25.2 M (+0.08 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 15,000 | 153 | 25,139,297 | 25.1 M to 25.1 M (+0.06 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 104 | 25,124,297 | 25.1 M to 25.1 M (+0.04 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 15,000 | 155 | 25,114,297 | 25.1 M to 25.1 M (+0.06 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 25,099,297 | 25.1 M to 25.1 M (+0.01 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 104 | 25,097,297 | 25.1 M to 25.1 M (+0.04 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 52 | 25,087,297 | 25.1 M to 25.1 M (+0.02 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 52 | 25,082,297 | 25.1 M to 25.1 M (+0.02 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 25,077,297 | 25.1 M to 25.1 M (+0.01 %) |
Aug 30 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 102 | 25,075,297 | 25.1 M to 25.1 M (+0.04 %) |
Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 25,065,297 | 25.1 M to 25.1 M (+0.02 %) |
Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 54 | 25,060,297 | 25.1 M to 25.1 M (+0.02 %) |
Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 25,055,297 | 25.1 M to 25.1 M (+0.02 %) |
Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 109 | 25,050,297 | 25 M to 25.1 M (+0.04 %) |
Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 20,000 | 218 | 25,040,297 | 25 M to 25 M (+0.08 %) |
Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 25,020,297 | 25 M to 25 M (+0.02 %) |
Aug 23 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 55 | 25,015,297 | 25 M to 25 M (+0.02 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 54 | 25,010,297 | 25 M to 25 M (+0.02 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 25,005,297 | 25 M to 25 M (+0.02 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 22 | 25,000,297 | 25 M to 25 M (+0.01 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 24,998,297 | 25 M to 25 M (+0.02 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 24,993,297 | 25 M to 25 M (+0.01 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 24,991,297 | 25 M to 25 M (+0.02 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 102 | 24,986,297 | 25 M to 25 M (+0.04 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 500 | 5 | 24,976,297 | 25 M to 25 M (0.00 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 101 | 24,975,797 | 25 M to 25 M (+0.04 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 19,950 | 201 | 24,965,797 | 24.9 M to 25 M (+0.08 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 50 | 1 | 24,945,847 | 24.9 M to 24.9 M (0.00 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 100 | 24,945,797 | 24.9 M to 24.9 M (+0.04 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 51 | 24,935,797 | 24.9 M to 24.9 M (+0.02 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 51 | 24,930,797 | 24.9 M to 24.9 M (+0.02 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 3,000 | 30 | 24,925,797 | 24.9 M to 24.9 M (+0.01 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 24,922,797 | 24.9 M to 24.9 M (+0.01 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 54 | 25,010,297 | 25 M to 25 M (+0.02 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 25,005,297 | 25 M to 25 M (+0.02 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 22 | 25,000,297 | 25 M to 25 M (+0.01 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 24,998,297 | 25 M to 25 M (+0.02 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 24,993,297 | 25 M to 25 M (+0.01 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 53 | 24,991,297 | 25 M to 25 M (+0.02 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 102 | 24,986,297 | 25 M to 25 M (+0.04 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 500 | 5 | 24,976,297 | 25 M to 25 M (0.00 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 101 | 24,975,797 | 25 M to 25 M (+0.04 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 19,950 | 201 | 24,965,797 | 24.9 M to 25 M (+0.08 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 50 | 1 | 24,945,847 | 24.9 M to 24.9 M (0.00 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 100 | 24,945,797 | 24.9 M to 24.9 M (+0.04 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 51 | 24,935,797 | 24.9 M to 24.9 M (+0.02 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 5,000 | 51 | 24,930,797 | 24.9 M to 24.9 M (+0.02 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 3,000 | 30 | 24,925,797 | 24.9 M to 24.9 M (+0.01 %) |
Aug 16 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 24,922,797 | 24.9 M to 24.9 M (+0.01 %) |
Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 24,920,797 | 24.9 M to 24.9 M (+0.01 %) |
Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 24,918,797 | 24.9 M to 24.9 M (+0.01 %) |
Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 20 | 24,916,797 | 24.9 M to 24.9 M (+0.01 %) |
Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 21 | 24,914,797 | 24.9 M to 24.9 M (+0.01 %) |
Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 15,000 | 159 | 24,912,797 | 24.9 M to 24.9 M (+0.06 %) |
Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 23 | 24,897,797 | 24.9 M to 24.9 M (+0.01 %) |
Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 12,000 | 139 | 24,895,797 | 24.9 M to 24.9 M (+0.05 %) |
Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 118 | 24,883,797 | 24.9 M to 24.9 M (+0.04 %) |
Aug 09 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 15,000 | 177 | 24,873,797 | 24.9 M to 24.9 M (+0.06 %) |
Jul 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 2,000 | 24 | 24,858,797 | 24.9 M to 24.9 M (+0.01 %) |
Jul 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 121 | 24,856,797 | 24.8 M to 24.9 M (+0.04 %) |
Jul 25 2019 | ENDV | ENDONOVO THERAPEUT ... | Collier Alan Brian | CEO | Buy | P | 0.01 | 10,000 | 121 | 24,846,797 | 24.8 M to 24.8 M (+0.04 %) |